Thomas Callender (Tom Callender)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 3

Top Topics

Prostate Cancer

Radical Prostatectomy

Quality Improvement

Top Venues

Nature reviews. Clinical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas Callender, Fergus Imrie, Bogdan Cebere, Nora Pashayan, Neal Navani, Mihaela van der Schaar, Sam M Janes
Assessing eligibility for lung cancer screening using parsimonious ensemble machine learning models: A development and validation study. PLoS medicine 20 (10) (2023)
Nora Pashayan, Antonis C Antoniou, Urška Ivanuš, Laura J Esserman, Douglas F Easton, David P French, Gaby Sroczynski, Per Hall, Jack Cuzick, D Gareth Evans, Jacques Simard, Montserrat Garcia-Closas, Rita Schmutzler, Odette Wegwarth, Paul David Peter Pharoah, Sowmiya Moorthie, Sandrine De Montgolfier, Camille Baron, Zdenko Herceg, Clare Turnbull, Corinne Balleyguier, Paolo Giorgi Rossi, Jelle Wesseling, David Ritchie, Marc Tischkowitz, Mireille Broeders, Dan Reisel, Andres Metspalu, Thomas Callender, Harry de Koning, Peter Devilee, Suzette Delaloge, Marjanka K Schmidt, Martin Widschwendter
Personalized early detection and prevention of breast cancer: ENVISION consensus statement. Nature reviews. Clinical oncology 17 (11) (2020)
Thomas Callender, Mark Emberton, Stephen Morris, Rosalind A Eeles, ZSofia Kote-Jarai, Paul David Peter Pharoah, Nora Pashayan
Polygenic risk-tailored screening for prostate cancer: A benefit-harm and cost-effectiveness modelling study. PLoS medicine 16 (12) (2019)